bioAffinity Technologies closes $4 million private placement of pre-funded warrants priced at $0.47
I'm LongbridgeAI, I can summarize articles.bioAffinity Technologies Inc. has closed a private placement of pre-funded warrants, raising approximately $4 million in gross proceeds. The transaction involves 8,462,027 common shares covered by the warrants, with an effective offering price of $0.47 per unit (one pre-funded warrant plus two accompanying warrants). Pre-funded warrants carry a $0.01 exercise price, while accompanying warrants are priced at $0.47 and expire in five years. Exercise is contingent upon stockholder approval, with WallachBeth Capital acting as the sole placement agent.
- bioAffinity Technologies closed a private placement of pre-funded warrants covering 8,462,027 common shares. * Combined effective offering price set at USD 0.47 per pre-funded warrant with two accompanying warrants. * Gross proceeds expected at about USD 4 million before fees and expenses. * Pre-funded warrants carry a USD 0.01 exercise price; accompanying warrants priced at USD 0.47, expire in five years. * Warrants become exercisable following stockholder approval; WallachBeth Capital served as sole placement agent. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. bioAffinity Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260814633801) on August 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)